These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1423 related items for PubMed ID: 23051009

  • 1. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N, Ito K, Hosoya T, Mimura J, Maruyama A, Noguchi N, Yagami K, Morito N, Takahashi S, Maher JM, Yamamoto M, Itoh K.
    Free Radic Biol Med; 2012 Dec 15; 53(12):2256-62. PubMed ID: 23051009
    [Abstract] [Full Text] [Related]

  • 2. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C, He S, Peng Y, Kushwaha KK, Lin J, Dong J, Wang B, Lin J, Shan S, Liu J, Huang K, Li D.
    J Mol Cell Cardiol; 2014 Nov 15; 76():33-45. PubMed ID: 25117469
    [Abstract] [Full Text] [Related]

  • 3. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B, Van Kampen E, Van Berkel TJ, Cruickshank SM, Van Eck M.
    Atherosclerosis; 2017 Jan 15; 256():35-46. PubMed ID: 27998825
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.
    Arterioscler Thromb Vasc Biol; 2014 Apr 15; 34(4):790-800. PubMed ID: 24526691
    [Abstract] [Full Text] [Related]

  • 8. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S, Blessing E, Preusch MR, Albrecht C, Bierhaus A, Andrassy M, Nawroth PP, Rosenfeld ME, Katus HA, Bea F.
    Eur J Clin Invest; 2011 Nov 15; 41(11):1164-71. PubMed ID: 21418204
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2006 Aug 15; 26(8):1858-63. PubMed ID: 16763157
    [Abstract] [Full Text] [Related]

  • 11. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C, Preusch MR, Hofmann G, Morris-Rosenfeld S, Blessing E, Rosenfeld ME, Katus HA, Bea F.
    Cardiovasc Res; 2010 May 01; 86(2):321-9. PubMed ID: 20110335
    [Abstract] [Full Text] [Related]

  • 12. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN, Tao LJ, Zhou J, Wang R, Lu MM, Fu X.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug 01; 39(8):743-8. PubMed ID: 22169423
    [Abstract] [Full Text] [Related]

  • 13. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q, Sun W, Wang X, Zhang K, Xi W, Gao P.
    Stem Cells Transl Med; 2015 Nov 01; 4(11):1294-301. PubMed ID: 26400926
    [Abstract] [Full Text] [Related]

  • 14. The absence of macrophage Nrf2 promotes early atherogenesis.
    Ruotsalainen AK, Inkala M, Partanen ME, Lappalainen JP, Kansanen E, Mäkinen PI, Heinonen SE, Laitinen HM, Heikkilä J, Vatanen T, Hörkkö S, Yamamoto M, Ylä-Herttuala S, Jauhiainen M, Levonen AL.
    Cardiovasc Res; 2013 Apr 01; 98(1):107-15. PubMed ID: 23341579
    [Abstract] [Full Text] [Related]

  • 15. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD, Yin M, Jing W, DU HQ, Ye HY, Shang YJ, Zhang L, Zou YY, Qu ZP, Pan J.
    Sheng Li Xue Bao; 2008 Feb 25; 60(1):43-50. PubMed ID: 18288357
    [Abstract] [Full Text] [Related]

  • 16. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinöhl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A.
    Arterioscler Thromb Vasc Biol; 2014 Oct 25; 34(10):2237-45. PubMed ID: 25104800
    [Abstract] [Full Text] [Related]

  • 17. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
    Freigang S, Ampenberger F, Spohn G, Heer S, Shamshiev AT, Kisielow J, Hersberger M, Yamamoto M, Bachmann MF, Kopf M.
    Eur J Immunol; 2011 Jul 25; 41(7):2040-51. PubMed ID: 21484785
    [Abstract] [Full Text] [Related]

  • 18. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P, Gandhi C, Prakash P, Dhanesha N, Grumbach IM, Dailey ME, Lentz SR, Chauhan AK.
    Arterioscler Thromb Vasc Biol; 2015 Nov 25; 35(11):2391-400. PubMed ID: 26427793
    [Abstract] [Full Text] [Related]

  • 19. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK, Lappalainen JP, Heiskanen E, Merentie M, Sihvola V, Näpänkangas J, Lottonen-Raikaslehto L, Kansanen E, Adinolfi S, Kaarniranta K, Ylä-Herttuala S, Jauhiainen M, Pirinen E, Levonen AL.
    Cardiovasc Res; 2019 Jan 01; 115(1):243-254. PubMed ID: 29917052
    [Abstract] [Full Text] [Related]

  • 20. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.
    Nahon JE, Hoekstra M, Havik SR, Van Santbrink PJ, Dallinga-Thie GM, Kuivenhoven JA, Geerling JJ, Van Eck M.
    Atherosclerosis; 2018 Jul 01; 274():120-127. PubMed ID: 29772480
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 72.